Male Female Both sexes Male Female Both sexes. Male Female Both sexes Male Female Both sexes 9.8% 11.1% 10.3% 1,057 1,002 2,059

Similar documents
Male Female Both sexes Male Female Both sexes 11 1,367 1, FIVE-YEAR SURVIVAL ( ) Male Female Both sexes Male Female Both sexes

Male Female Both sexes Male Female Both sexes 10 1,333 1, FIVE-YEAR SURVIVAL ( ) Male Female Both sexes Male Female Both sexes

1, FIVE-YEAR SURVIVAL ( ) 88.5% 9,347

Male Female Both sexes Male Female Both sexes FIVE-YEAR SURVIVAL ( )

Male Female Both sexes Male Female Both sexes FIVE-YEAR SURVIVAL ( )

BRAIN AND NERVOUS SYSTEM CANCER

BRAIN AND NERVOUS SYSTEM CANCER

ALL CANCER (EXCLUDING NMSC)

ALL CANCER (EXCLUDING NMSC)

CANCER INCIDENCE AND SURVIVAL STATISTICS FOR NORTHERN IRELAND

Health Inequalities. Additional tables to accompany the 2016 Director of Public Health Annual Report

CDI rate per 1,000 bed days increased by 27% during April-June 2015 compared to January- March 2015.

Macmillan-NICR Partnership: GP Federation Cancer Profiles (with Prevalence )

Statistics on Smoking Cessation Services in Northern Ireland: 2014/15

The Northern Ireland breast screening programme

Care of bladder cancer patients diagnosed in Northern Ireland 2010 & 2011 (Summary)

Funding Opportunities for Public Health Research

Northern Ireland breast screening. Helping you decide

Northern Ireland breast screening. Helping you decide

The Cost of Alcohol Frequent Attenders: Staging an Intervention

Northern Ireland Cervical Screening Programme

Northern Ireland Prostate Cancer Service

Journal of the Statistical and Social Inquiry Society of Ireland Volume XXXIX. D.W. Donnelly & A.T. Gavin

NORTHERN IRELAND BREAST SCREENING PROGRAMME ANNUAL REPORT & STATISTICAL BULLETIN

ALCOHOL RELATED DEATHS REGISTERED IN NORTHERN IRELAND ( )

Statistics on Smoking Cessation Services in Northern Ireland: 2008/2009

WHERE NEXT FOR CANCER SERVICES IN NORTHERN IRELAND? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE

Public Health Annual Scientific Conference Wednesday 10 June Making Life Better: Improving Health and Care for Adults

NICaN workshop: Colorectal Cancer Follow-up

Breast awareness: looking out for changes

Statistics from the Northern Ireland Drug Misuse Database: 1 April March 2012

Skin Cancer trends in Northern Ireland and consequences for provision of dermatology services

From the Deputy Chief Medical Officer / Chief Dental Officer Dr Anne Kilgallen / Simon Reid. Circular HSC (SQSD) (NICE NG30) 37/16

ehealth and Data Analytics Dementia Pathfinder Programme Dementia Analytics Research User Group (DARUG) PPI Steering Group

Consumer Impact! Newsletter of the Northern Ireland Cancer Research Consumer Forum Northern Ireland Cancer Research Consumer Forum

The Prevalence of Autism (including Asperger Syndrome) in School Age Children in Northern Ireland 2017

Cancer survival by stage at diagnosis in Wales,

Public Health Agency NORTHERN IRELAND BREAST SCREENING PROGRAMME ANNUAL REPORT & STATISTICAL BULLETIN QUALITY ASSURANCE REFERENCE CENTRE

United Kingdom and Ireland Association of Cancer Registries (UKIACR) Performance Indicators 2018 report

Officer presenting: Director of Health and Community. Title of Report: Tobacco Control Northern Ireland Briefing Paper

Macmillan-NICR Partnership: Cancer Data Landscape in Northern Ireland April 2018

Statistics from the Northern Ireland Drug Misuse Database: 1 April March 2011

NORTHERN IRELAND BREAST SCREENING PROGRAMME ANNUAL REPORT & STATISTICAL BULLETIN

Care of lung cancer patients in Northern Ireland diagnosed 2014

Focus on alcohol. A guide to drinking and health

Alcohol and Drug Commissioning Framework for Northern Ireland Consultation Questionnaire.

What is Hepatitis? easy read

Annual surveillance report 2015

Cancer Trends in Northern Ireland: D. Fitzpatrick, A. Gavin, D. Donnelly

Northern Ireland cervical screening programme. Information for primary care and smear takers

Strategy for Personal and Public Involvement (PPI)

Childminding as a profession. A guide to registration

Validation Study Result Form

Overall Statistics for Northern Ireland as at 14 May 2005

North Belfast Locality Planning Group Action Plan

The Burden of Dental disease in Children. England, Wales and Northern Ireland. Professor Jimmy Steele Newcastle University

Breast awareness Looking out for changes

Clinical Audit Report

MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question.

Children and Young Peoples Strategic Partnership Outcomes Based Planning Presentation

TESTING TIMES TO COME? AN EVALUATION OF PATHOLOGY CAPACITY IN NORTHERN IRELAND NOVEMBER 2016

Third All Ireland Cancer Statistics Report

N. Ireland Cancer Registry Queen s University Belfast, Mulhouse Building, Grosvenor Road, Belfast, BT12 6BJ Website

Northern Ireland Substitute Prescribing Database Report 31 st March 2015

Joint Strategic Needs Assessment

Dr Rebecca Preston FRCP FRCR Consultant Radiologist Course Director Radiology Lead for Cardiac CT Guy s and St Thomas NHS Foundation Trust London, UK

SCREENING MATTERS - Issue 26

2) {p p is an irrational number that is also rational} 2) 3) {a a is a natural number greater than 6} 3)

SHORT ANSWER. Write the word or phrase that best completes each statement or answers the question. Simplify the expression.

Northern Ireland Substitute Prescribing Database Report 31 st March 2013

Life After Prostate Cancer Diagnosis Research Study

Annual surveillance report 2016

Children and Young Peoples Strategic Partnership Outcomes Based Planning Presentation

Mud Madness Sunday 25 th September 2016

Swine Flu. Media Briefing. 13 January 2011

Table 15.1 Summary information for kidney cancer in Ireland, Ireland RoI NI female male female male female male % of all new cancer cases

United Kingdom and Ireland Association of Cancer Registries (UKIACR) Performance Indicators 2017 report Published XX June 2017

CONFIRMED INFLUENZA ISOLATES IN NORTHERN IRELAND - NICE GUIDANCE ON USE OF ANTIVIRALS NOW APPLIES

Barriers and facilitators to vaccination in pregnancy: a qualitative study in Northern Ireland, 2017

Living the Way You Want Series. Going to the chemist Easy Read. A Down s Syndrome Association Publication

Opportunities to become involved

Female Genital Mutilation (FGM) Enhanced Dataset

Breastfeeding comparisons between initiation, days and 6-8 weeks in

Take Home Naloxone Report on supply and use to reverse an overdose

SUMMARY: YEAR OLDS WITH CANCER IN ENGLAND: INCIDENCE, MORTALITY AND SURVIVAL (2018)

Welsh Cancer Intelligence and Surveillance Unit Uned Gwybodaeth a Gwyliadwriaeth Canser Cymru

Implementing Recovery through Organisational Change. Fiona Houston, Service Improvement Manager 2014

MENTAL HEALTH, BEREAVEMENT AND SUICIDE

Abdominal aortic aneurysm (AAA) screening Things you need to know

What do you need? A UK-wide survey of people with diagnosed HIV

The Plastic Surgery See and Treat Skin Cancer Clinic (SATSKIN)

Paediatric Dentistry Referral Guidelines

Cancer Screening Nottingham City Joint Strategic Needs Assessment April 2009

Digoxin use after diagnosis of colorectal cancer and survival: a population-based cohort study.

INVOLVING YOU. Personal and Public Involvement Strategy

Cancer Data Review ( ) Selected Zip Codes of Warminster, Warrington, and Horsham, PA

Public Health Agency and Drug and Alcohol Coordination Teams. Local Drug and Alcohol Incident Protocol

Digoxin use after diagnosis of colorectal cancer and survival: A population-based cohort. study

Multi-Professional Breast Cancer Pre-habilitation: Education and Self-Empowerment. Gillian McCollum Lymphoedema Lead Belfast HSC Trust

Transcription:

LUNG CANCER NUMBER OF CASES PER YEAR (2011-2015) NUMBER OF DEATHS PER YEAR (2011-2015) Male Female Both sexes Male Female Both sexes 667 543 1,210 1 546 412 957 1 FIVE-YEAR SURVIVAL (2005-2009) 23-YEAR PREVALENCE (2015) Male Female Both sexes Male Female Both sexes 9.8% 11.1% 10.3% 1,057 1,002 2,059 INCIDENCE In 2011-2015 there were 667 male and 543 female patients diagnosed with lung cancer each year. The lifetime risk of developing a lung cancer was 1 in 21 for men and 1 in 28 for women. Incidence trends Table 1: Incidence of lung cancer by sex and year of diagnosis: 2006-2015 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Male 574 602 656 620 639 658 660 687 661 671 Female 369 424 408 462 422 463 535 555 593 569 Both sexes 943 1,026 1,064 1,082 1,061 1,121 1,195 1,242 1,254 1,240 Over the ten year period 2006-2015, the number of lung cancer cases increased by 17% in men from 574 to 671 and 54% among women from 369 in to 569. Figure 1: Trends in lung cancer incidence rates by sex: 1993-2015 After accounting for the increasing number of older people in the NI population, lung cancer incidence rates decreased among males during 1993-2015 by an average of 0.7% per year. However for the same period, female incidence rates increased by an average of 0.7% per year between 1993 and 2006 and 3.4% per year between 2006 and 2015. These patterns reflect historic smoking trends, (the most important risk factor for lung cancer), with decreasing rates of smoking among males and increasing rates among females influencing recent trends. 1 Mean yearly incidence data for period 2011-2015 has been rounded to nearest integer, and thus some numbers in tables will not add to give the exact total. 1

2 Lung Cancer Incidence and age Lung cancer risk is strongly related to age with 74% of patients diagnosed over the age of 65 years. Incidence rates are highest among men aged 85-89 and among women aged 75-79. Figure 2: Incidence of lung cancer by age and sex: 2011-2015 Table 2: Average number of lung cancers diagnosed per year by sex and age: 2011-2015 Age Male Female Total 0 to 49 19 17 36 50 to 64 145 130 276 65 to 74 244 180 423 75 and over 260 216 474 All ages 667 543 1,210 Due to rounding of yearly averages, All ages may not equal the sum of age categories in tables. Incidence by Trust area Lung cancer incidence rates in 2011-2015 were 29% higher than the NI average among people living within the Belfast HSCT area. Incidence rates were lower than the NI average in the Northern and South- Eastern Trust areas. Figure 3: Lung cancer incidence rates compared to the NI average by sex and HSC Trust of residence: 2011-2015 Significantly higher than average Significantly lower than average 2

Lung cancer 3 Incidence by deprivation Lung cancer incidence is higher among the most deprived communities in Northern Ireland. This likely relates to higher smoking prevalence in these areas. Figure 4: Lung cancer incidence rates compared to the NI average by sex and deprivation quintile: 2011-2015 Incidence by stage Cancer stage is a way of describing the size of a cancer and how far it has grown and spread. This information is important in helping decide what treatments are needed and stage of disease at diagnosis is strongly associated with cancer survival. Figure 5: Lung cancer stage distribution: 2011-2015 In 2011-2015 over four fifths (87.1%) of lung cancer patients in Northern Ireland were assigned a stage at diagnosis. The majority of lung cancer patients were diagnosed at a later stage with 43.5% (50.0% of staged disease) diagnosed at stage IV compared to 14.1% (16.2% of staged disease) at stage I. 3

4 Lung Cancer SURVIVAL The net survival was 31.1% at one year, and 10.3% at five years for lung cancer patients diagnosed in 2005 to 2009. Table 3: Five-year lung cancer survival by survival time and sex: patients diagnosed 2005-2009 Time since diagnosis Diagnosed 2005-2009 Male Female Both sexes 6 months 45.8% 51.4% 48.1% 1 year 29.7% 33.3% 31.1% 5 years 9.8% 11.1% 10.3% Survival Trends Five-year survival for lung cancer has improved from the 1993-1999 diagnosis period to the 2005-2009 diagnosis period; increasing for men from 7.5% to 9.8% and for women from 9.1% to 11.1%. Table 4: Five-year lung cancer survival by period of diagnosis and sex Period of diagnosis Male Female Both sexes 1993-1999 7.5% 9.1% 8.1% 2000-2004 8.3% 9.2% 8.6% 2005-2009 9.8% 11.1% 10.3% Survival and stage Stage at diagnosis is one of the most important factors in lung cancer survival with five year survival decreasing as stage increases. Five-year survival ranged from 39.5% for early (stage I) disease to 1.6% for late (stage IV) disease highlighting the importance of early diagnosis. Differences in survival between males and females diagnosed with stage I lung cancer is also apparent with 37.0% of males surviving five years compared to 43.5% of females. Figure 6: Five year survival from lung cancer by stage of diagnosis: patients diagnosed 2006-2010 4

Lung cancer 5 MORTALITY Mortality statistics are provided by the Northern Ireland General Registrar s Office. In 2011-2015 there were 546 male and 412 female deaths from lung cancer each year. Mortality trends Figure 7: Trends in lung cancer mortality rates by sex: 1993-2015 Over the last ten years 2006-2015, the number of lung cancer deaths has increased by 3% among men from 526 to 541 and 30% among women from 333 to 432. When adjusted for age and population change, lung cancer mortality rates decreased for males by -1.4% per year during 1993-2015, but increased by 1.0% per year for females. PREVALENCE At the end of 2015 there were 2,059 people living in NI who had been diagnosed with lung cancer from 1993-2015 (Table 5). Of these, 51.3% were male, 57.3% were aged 70 and over and 33.0% had been diagnosed in the previous year. Table 5: Number of people living with lung cancer at the end of 2015 who were diagnosed from 1993-2015 by time since diagnosis Sex Age 0-1 year Time since diagnosis 1-5 years 5-10 years 10-23 years 23-year Prevalence Male 0-69 168 160 79 50 457 70+ 192 213 91 104 600 All ages 360 373 170 154 1,057 Female 0-69 145 183 50 45 423 70+ 174 225 89 91 579 All ages 319 408 139 136 1,002 Both sexes 0-69 313 343 129 95 880 70+ 366 438 180 195 1,179 All ages 679 781 309 290 2,059 5

6 Lung Cancer FURTHER INFORMATION Further data is available from the Northern Ireland Cancer Registry web site: www.qub.ac.uk/nicr ACKNOWLEDGEMENTS NICR is funded by the Public Health Agency and is hosted by Queen s University, Belfast. This work uses data provided by patients and collected by the NHS as part of their care and support. NI Cancer Registry Phone: +44 (0)28 9097 6028 e-mail: nicr@qub.ac.uk 6